[Jiuzhou Pharmaceutical: holding subsidiary Carbamazepine sustained-release tablets (Ⅱ) receives Drug Registration Certificate] June 12, Jiuzhou Pharmaceutical announced that Jiuzhou Biology, the company's holding subsidiary, recently received the Drug Registration Certificate of Carbamazepine sustained-release tablets (Ⅱ) approved and issued by the State Drug Administration.